Suning Chen

2.3k total citations
95 papers, 1.5k citations indexed

About

Suning Chen is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Suning Chen has authored 95 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 38 papers in Molecular Biology and 29 papers in Genetics. Recurrent topics in Suning Chen's work include Acute Myeloid Leukemia Research (33 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Acute Lymphoblastic Leukemia research (16 papers). Suning Chen is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Acute Lymphoblastic Leukemia research (16 papers). Suning Chen collaborates with scholars based in China, Germany and United States. Suning Chen's co-authors include Libo Yao, Aidong Wen, Jian Zhang, Sumaiyah K. Rehman, Xiaofeng Lai, Yifang Wei, Xingmei Zhu, Shentong Yu, Jiän Zhang and Yongzheng Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Suning Chen

83 papers receiving 1.5k citations

Peers

Countries citing papers authored by Suning Chen

Since Specialization

Citations

This map shows the geographic impact of Suning Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suning Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suning Chen more than expected).

Fields of papers citing papers by Suning Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suning Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suning Chen. The network helps show where Suning Chen may publish in the future.

Co-authorship network of co-authors of Suning Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Suning Chen. A scholar is included among the top collaborators of Suning Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suning Chen. Suning Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS) 2024 ·Blood ·Huafeng Wang, Xudong Wei, Yang Liang, (unknown), (unknown), Chunkang Chang, Suning Chen, (unknown), Zi Chen, (unknown), Lihui Liu, Xiaohong Tian, Zhang Zhang, (unknown), Dajun Yang, Yifan Zhai, Jie Jin	0
2	Efficacy and Safety of Gilteritinib-Based Therapy Combinated with Allo-HSCT in Relapsed or Refractory Acute Myeloid Leukemia Patients with Positive FLT3-ITD Mutation 2024 ·Blood ·Jian Zhang, Yang Xu, Shengli Xue, Miao Miao, Ying Wang, Suning Chen, Depei Wu, Huiying Qiu	0
3	Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology 2024 ·British Journal of Haematology ·Rong Wang, (unknown), Yuan Zhang, (unknown), Minghui Duan, Min Xiao, Jin Wang, Suning Chen, Qian Wang, Jianyao Huang, (unknown), (unknown), Jieyu He, Feng Chen, Lei Fan, Guanyu Yang, Wenyi Shen, Yongyue Wei, Jianyong Li	1
4	XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer 2024 ·Cancer Letters ·Jiajia Wang, (unknown), Peng Shen, Cong Fan, Pan Zhao, Yao Shen, Kewei Dong, Rui Ling, Suning Chen, J. Zhang	18
5	Effective treatment with Gilteritinib-based regimens for FLT3-mutant extramedullary relapse in acute promyelocytic leukemia 2023 ·Hematology ·(unknown), Yu Chen, (unknown), Yizhi Jiang, (unknown), Suning Chen	0
6	A Real-World Evidence on Effectiveness and Safety of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia 2023 ·Blood ·Huifen Zhou, Miao Miao, (unknown), (unknown), (unknown), Xinhui Zhang, Xiaofei Yang, Suning Chen, (unknown), (unknown)	0
7	P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY 2023 ·HemaSphere ·Jing Lu, Huifen Zhou, Xin Zhou, Yonggong Yang, (unknown), Miao Miao, Xiaofei Yang, Suning Chen	1
8	LPCAT3 is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysis 2022 ·Translational Cancer Research ·Ke Peng, Xiebing Bao, Chenxi Liu, (unknown), (unknown), (unknown), Xing Wang, Depei Wu, Xiao Ma, Dan Liu, Suning Chen	16
9	The impact of early molecular response in children and adolescents with chronic myeloid leukemia treated with imatinib: a single-center study from China 2018 ·Leukemia & lymphoma ·(unknown), Zhao Zeng, Jiannong Cen, Jun Zhang, (unknown), Chunxiao Wu, (unknown), Yong Wang, Huiying Qiu, Suning Chen, Jinlan Pan	4
10	Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple Myeloma 2018 ·Cellular Physiology and Biochemistry ·(unknown), Bin Liu, Shoubao Ma, Jubin Zhang, (unknown), (unknown), Mingqing Zhu, Suning Chen, Xiaojin Wu, Depei Wu	19
11	Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS 2016 ·Cancer Biology & Therapy ·Ruohan Zhang, Hongyu Qiao, Suning Chen, Xu Chen, Kefeng Dou, (unknown), Jian Zhang	62
12	Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib 2015 ·Tumor Biology ·Suning Chen, Xingmei Zhu, Hongyu Qiao, Mingxiang Ye, Xiaofeng Lai, Shentong Yu, Likun Ding, Aidong Wen, Jian Zhang	36
13	Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines 2015 ·PLoS ONE ·Haiping Dai, Stefan Ehrentraut, Stefan Nagel, Sonja Eberth, Claudia Pommerenke, Wilhelm G. Dirks, Robert Geffers, Srilaxmi Kalavalapalli, Maren Kaufmann, (unknown), (unknown), Suning Chen, Hans G. Drexler, Roderick A.F. MacLeod	17
14	Microarray CGH analysis of hematological patients with del(20q) 2015 ·International Journal of Hematology ·Chunxiao Wu, Jinlan Pan, Huiying Qiu, Yongquan Xue, Suning Chen, Yafang Wu, Jun Zhang, (unknown), Yong Wang, Juan Shen, (unknown)	6
15	The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case series 2014 ·Cancer Genetics ·Jinlan Pan, Chunxiao Wu, Yongquan Xue, Huiying Qiu, Suning Chen, Jun Zhang, (unknown), Yafang Wu, Yong Wang, Juan Shen, (unknown)	5
16	Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells 2014 ·Breast Cancer Research and Treatment ·Yifang Wei, Xiaofeng Lai, Shentong Yu, Suning Chen, Yongzheng Ma, Yuan Zhang, Huichen Li, Xingmei Zhu, Libo Yao, Jiän Zhang	300
17	The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure 2011 ·Leukemia Research ·Hui Jiang, Yongquan Xue, Qinrong Wang, Jinlan Pan, Yafang Wu, Jun Zhang, (unknown), Qian Wang, Guangsheng He, (unknown), Depei Wu, Suning Chen	20
18	A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia 2010 ·Cancer Genetics and Cytogenetics ·Jinlan Pan, Yongquan Xue, Huiying Qiu, Suning Chen, Jun Zhang, Yafang Wu, Juan Shen, Yong Wang	1
19	Autophagy is a therapeutic target in anticancer drug resistance 2010 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Suning Chen, Sumaiyah K. Rehman, (unknown), Aidong Wen, Libo Yao, Jian Zhang	310
20	Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration 2008 ·Experimental Hematology ·Huiying Qiu, Yongquan Xue, Jun Zhang, Jinlan Pan, Haiping Dai, Yafang Wu, Yong Wang, Suning Chen, Depei Wu	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact